论文部分内容阅读
目的:观察经尿道前列腺等离子电切术联合剜除术治疗前列腺增生症临床疗效。方法:回顾性选择2014年4月至2015年4月该院收治的49例前列腺增生临床资料,均采用经尿道前列腺等离子电切术联合剜除术治疗,观察手术指标,并比较术前术后IPSS评分及最大尿流率。结果:手术时间65~125 min,平均(78.60±6.30)min,术后置管时间6~9 d,平均(7.10±0.9)d,住院时间7~11 d,平均(7.30±0.80)d,术后有2例患者出现暂行时尿失禁情况,发生率为4.89%;术后IPSS评分明显小于术前,最大尿流率明显大于手术前(P<0.05)。结论:经尿道前列腺等离子电切术联合剜除术治疗前列腺增生症临床疗效显著,且具安全性高、预后效果佳等优点,具临床推广价值。
Objective: To observe the clinical efficacy of transurethral resection of prostate with excision of prostate in the treatment of benign prostatic hyperplasia. Methods: The clinical data of 49 cases of benign prostatic hyperplasia treated in our hospital from April 2014 to April 2015 were retrospectively selected. All of them were treated by transurethral resection of prostate and excision. The operative indexes were observed and compared before and after operation IPSS score and maximum flow rate. Results The operation time ranged from 65 to 125 minutes, with an average of (78.60 ± 6.30) min and postoperative catheterization time ranging from 6 to 9 days (mean, 7.10 ± 0.9 days, 7 to 11 days, average 7.30 ± 0.80 days, Postoperative transient urinary incontinence occurred in 2 patients, with an incidence rate of 4.89%. The postoperative IPSS score was significantly less than preoperative and the maximum urinary flow rate was significantly greater than before surgery (P <0.05). CONCLUSION: Transurethral resection of prostate combined with cystaectomy in the treatment of benign prostatic hyperplasia has obvious clinical curative effect, high safety and good prognosis. It has clinical value of popularization.